BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Research

WuXi Biologics Introduces WuXiUI™: Enhancing Bioprocessing for Efficiency and Quality in Commercial Manufacturing

WuXiUI™ ultra-intensified fed-batch platform offers a new process option for maximum flexibility to meet various clients' needs in biologics d...

October 17, 2023 | News

ABL Bio Achieves Regulatory Clearance for Innovative Bispecific Antibody in Solid Tumor; GenScript ProBio Commends Milestone Collaboration

ABL103 is a novel T-cell engaging bispecific antibody and demonstrates efficacious anti-tumor activity via B7-H4 mediated 4-1BB activation in tumor mi...

October 13, 2023 | News

Dirk Lange Reveals Merck's Historic Leap as the First CTDMO to Offer Integrated mRNA Services: A Blueprint for Advancing Biopharma

In this interview, we explore the significance of Merck's €1 billion investment in advancing mRNA technologies, the impact of their acqu...

October 11, 2023 | News

Emmes acquires VaxTRIALS

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical inn...

October 06, 2023 | News

WuXi Bio Applauds Amicus on FDA Approval for Pompe Disease Therapy

Pombiliti™, a recombinant human GAA enzyme (rhGAA) naturally expressed with high levels of bis-M6P (Mannose 6-Phosphate), was started at WuXi Biologi...

October 02, 2023 | News

Cellectricon expands neuroscience contract research portfolio with new Neuroplasticity services

Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, announced the launch of a new service module for neuroplasticit...

September 27, 2023 | News

Merck to Become First Provider to Offer Fully Integrated mRNA Services

New sites at Darmstadt and Hamburg complement Merck’s global integrated mRNA service network with pre-clinical to commercial capabilities Company&...

September 27, 2023 | News

China-Africa medical cooperation broadens under BRI

From there, he can admire the breathtaking views of the sleek, curved structure and the intricately layered sunshade components, showcasing the marvels of ...

September 04, 2023 | News

Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership

As leaders in their respective fields, this strategic partnership marks an important milestone in both companies' business growth and development. Also, it...

June 28, 2023 | News

Australia's First End-to-End mRNA CDMO Facility to Boost Vaccine Production and Research Capabilities

What is the significance of the first end-to-end mRNA process contract development and manufacturing organization (CDMO) establishment in Australia? ...

May 17, 2023 | News

Melanoma Research Alliance awards $6.3M in grants for prevention, detection, and treatment

MRA-funded research spans the entire spectrum of the disease including melanoma prevention, diagnosis, treatment, and metastatic disease. Melanoma is the d...

May 02, 2023 | News

Cytiva supports BioCina with first GMP production and development facility for mRNA in Australia

Expanded facility to manufacture mRNA-based therapies and vaccines Researchers at the University of Adelaide will address the design and ma...

April 26, 2023 | News

Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer announced that Clev...

April 18, 2023 | News

Emmes' Acquisition of Essex Management Boosts Its Technology Prowess to Help Solve Global Health Challenges

Biopharma APAC sat down with Matt Honan (MH), Vice president and global head of corporate development at Emmes and Ching Tian (CT), Chief In...

April 06, 2023 | Influencers

Stay Connected